Gtcr Investment Xi Llc Sells 6,480,000 Shares of Sotera Health (NASDAQ:SHC) Stock

Sotera Health Company (NASDAQ:SHC) Director Gtcr Investment Xi Llc sold 6,480,000 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the transaction, the director directly owned 22,735,301 shares in the company, valued at $371,267,465.33. The trade was a 22.18% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Gtcr Investment Xi Llc also recently made the following trade(s):

• On Monday, November 10th, Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock. The stock was sold at an average price of $15.65, for a total transaction of $187,800,000.00.

Sotera Health Stock Up 1.1%

Shares of NASDAQ:SHC opened at $16.75 on Friday. The firm has a fifty day moving average of $16.31 and a 200 day moving average of $14.36. Sotera Health Company has a 52-week low of $9.53 and a 52-week high of $17.78. The company has a debt-to-equity ratio of 4.04, a quick ratio of 2.18 and a current ratio of 2.38. The firm has a market capitalization of $4.76 billion, a PE ratio of 88.16 and a beta of 1.81.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.04. The firm had revenue of $311.31 million during the quarter, compared to analyst estimates of $303.63 million. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. As a group, research analysts anticipate that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of recent research reports. JPMorgan Chase & Co. increased their price target on shares of Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Barclays increased their target price on shares of Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Piper Sandler boosted their price target on shares of Sotera Health from $15.00 to $17.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. BMO Capital Markets initiated coverage on Sotera Health in a research note on Thursday, November 13th. They set an “outperform” rating and a $19.00 price objective on the stock. Finally, Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $17.80.

Institutional Investors Weigh In On Sotera Health

Large investors have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. raised its stake in shares of Sotera Health by 5.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,415,282 shares of the company’s stock valued at $16,502,000 after acquiring an additional 68,087 shares during the last quarter. Deutsche Bank AG increased its holdings in Sotera Health by 1,902.2% during the 1st quarter. Deutsche Bank AG now owns 165,605 shares of the company’s stock valued at $1,931,000 after purchasing an additional 157,334 shares during the period. Invesco Ltd. raised its position in Sotera Health by 10.4% during the 1st quarter. Invesco Ltd. now owns 306,398 shares of the company’s stock valued at $3,573,000 after purchasing an additional 28,892 shares during the last quarter. Nuveen LLC purchased a new stake in Sotera Health in the 1st quarter worth approximately $4,433,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in Sotera Health by 3,690.1% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company’s stock worth $31,000 after buying an additional 2,620 shares during the period. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.